We are live on ! Find out more
AA

AlphaMark Advisors Portfolio holdings

AUM $231M
1-Year Est. Return 19.98%
This Fund
S&P 500
This Quarter Est. Return
+4.85%
1 Year Est. Return
+19.98%
3 Year Est. Return
+26.38%
5 Year Est. Return
+72.27%
10 Year Est. Return
+180.76%
AUM
$217M
AUM Growth
-$5.69M
Cap. Flow
-$14.7M
Cap. Flow %
-6.79%
Top 10 Hldgs %
44.19%
Holding
671
New
37
Increased
83
Reduced
179
Closed
34
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAC icon
426
Bank of America
BAC
$435B
$8K ﹤0.01%
277
+52
+23% +$1.48K
BNS icon
427
Scotiabank
BNS
$107B
$8K ﹤0.01%
150
D icon
428
Dominion Energy
D
$60.8B
$8K ﹤0.01%
150
DVN icon
429
Devon Energy
DVN
$52.1B
$8K ﹤0.01%
+170
New +$8.55K
FEX icon
430
First Trust Large Cap Core AlphaDEX Fund
FEX
$1.57B
$8K ﹤0.01%
90
FGM icon
431
First Trust Germany AlphaDEX Fund
FGM
$98M
$8K ﹤0.01%
195
-250
-56% -$9.69K
GIS icon
432
General Mills
GIS
$19.1B
$8K ﹤0.01%
100
-625
-86% -$53.4K
JKS
433
JinkoSolar
JKS
$793M
$8K ﹤0.01%
190
CALY
434
Callaway Golf Company
CALY
$3.32B
$8K ﹤0.01%
400
OBDC icon
435
Blue Owl Capital
OBDC
$5.34B
$8K ﹤0.01%
574
PARA
436
DELISTED
Paramount Global Class B
PARA
$8K ﹤0.01%
475
+275
+138% +$4.97K
SHOP icon
437
Shopify
SHOP
$152B
$8K ﹤0.01%
120
SVOL icon
438
Simplify Volatility Premium ETF
SVOL
$521M
$8K ﹤0.01%
352
-239
-40% -$5.32K
THW
439
abrdn World Healthcare Fund
THW
$536M
$8K ﹤0.01%
600
WY icon
440
Weyerhaeuser
WY
$18B
$8K ﹤0.01%
250
NWBO
441
DELISTED
Northwest Biotherapeutics, Inc. Common stock
NWBO
$8K ﹤0.01%
14,007
BF.B icon
442
Brown-Forman Class B
BF.B
$13.2B
$7K ﹤0.01%
104
BTI icon
443
British American Tobacco
BTI
$131B
$7K ﹤0.01%
196
CNC icon
444
Centene
CNC
$30.7B
$7K ﹤0.01%
100
DOCT
445
FT Vest US Equity Deep Buffer ETF October
DOCT
$385M
$7K ﹤0.01%
200
-4,800
-96% -$161K
MET.PRA icon
446
MetLife Inc Floating Rate Series A
MET.PRA
$506M
$7K ﹤0.01%
300
-510
-63% -$11.6K
NLY icon
447
Annaly Capital Management
NLY
$17.1B
$7K ﹤0.01%
357
RYLD icon
448
Global X Russell 2000 Covered Call ETF
RYLD
$1.37B
$7K ﹤0.01%
400
SEDG icon
449
SolarEdge
SEDG
$2.51B
$7K ﹤0.01%
25
STWD icon
450
Starwood Property Trust
STWD
$5.92B
$7K ﹤0.01%
380

Similar funds

AlphaMark Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, AlphaMark Advisors held 671 positions worth $217M, down 2.6% from $223M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

AlphaMark Advisors withdrew a net $14.7M in Q2 2023, closing 34 positions and reducing 179 holdings. Its most notable exit was Edwards Lifesciences, an estimated $2.23M position sold in full.

By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 6.3% a quarter earlier, followed by Consumer Staples and Healthcare.

Against the trend, AlphaMark Advisors opened a new position in Albemarle worth $530K.

  • AlphaMark Advisors's largest Q2 2023 buy was Albemarle: 2,377 shares worth $530K.
  • AlphaMark Advisors added most to Janus Henderson AAA CLO ETF in Q2 2023, an estimated $1.42M increase.
  • AlphaMark Advisors's biggest Q2 2023 reduction was State Street Technology Select Sector SPDR ETF, cutting an estimated $1.96M.
  • AlphaMark Advisors fully exited Edwards Lifesciences in Q2 2023, selling an estimated $2.23M.
  • AlphaMark Advisors's ten largest holdings make up 44% of its $217M portfolio in Q2 2023.
  • AlphaMark Advisors opened 37 new positions and closed 34 in Q2 2023.
  • AlphaMark Advisors's portfolio value fell 2.6% quarter-over-quarter to $217M.

Based on AlphaMark Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.